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Abstract
Background: Transplantable organs are scarce everywhere. Therefore, countries have developed
policies to support the efficient use of potential donors. Nevertheless, the shortage of organs
remains. Were these policies in vain? The aim of this study is to assess the impact of donor policies
on donor procurement in 10 Western European countries from 1995 to 2005.
Method: To assess the impact of the donor policies we studied the conversion of potential donors
into effectuated donors. 80% of the donors died from CVAs or a (traffic) accident. We considered
these mortality rates to be a good proxy for potential donors. Here we call the conversion of
potential donors into actual donors 'the donor efficiency rate by proxy'.
Results: The mortality rates for CVA and (traffic) accidents have decreased in the countries under
study. At the same time, in most countries the donor efficiency rates have steadily increased. The
variance in donor efficiency rates between countries has also increased from 1995 to 2005. Four
countries introduced a new consent system or changed their existing system, without (visible) long-
term effects.
Conclusion: The overall increase in donor efficiency means that the efforts to improve donor
policies have paid off. However, substantial differences between countries were found. The success
of donor policies in terms of the number of absolute donors is blurred by the success of policies
on traffic safety and CVA treatment. It remains unclear which specific policy measures are
responsible for the increase in donor efficiency rates. This increase is not related to having a
presumed consent system. Furthermore, an analysis of countries that introduced a new consent
system or changed their system showed no effect on donor efficiency.
Background
Transplantable organs are scarce throughout the world.
The discrepancy between the number of people listed on
a national organ transplant waiting list and the number of
post mortem organ donations per year results in long
waiting times for patients to receive an organ [1,2]. In
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other words, the supply of organs that can be used for a
transplant does not meet the need. The urgency of this
problem was once again addressed by the EU Health
Commissioner Markos Kyprianou in 2007 [3].
To deal with the scarcity of organs, countries have devel-
oped national organ donation policies. In most countries
these donor policies consist of a legislative system which
regulates consent for donation [4] and additional policy
measures. Basically, there are two kinds of legislative sys-
tems: explicit consent and presumed consent. In an
explicit consent system, the donor has to authorize organ
removal after his death in the form of an advance directive
or a codicil, or by registration in a national registry. If the
deceased's wishes are unknown, next of kin are asked to
consent. A presumed consent system does not require to
obtain consent, either from the donor or from the next of
kin; it is sufficient to verify that the deceased has not
objected during his lifetime to becoming a donor [4]. In
all countries, the group of non-registered residents is
larger than the group of registered residents. Thus, pre-
sumed consent countries have larger pools of donor-con-
sent than explicit consent countries, which might
automatically result in greater numbers of donors in the
former. Several authors have argued that differences in
organ donation rates between consent systems prove that
a presumed consent system leads to a more effective pro-
curement of donors [5-7].
Other policy measures are directed at optimizing the proc-
ess of donor procurement. Examples of such measures are
hospital programs like Donor Action [8,9]. and EDHEP
[10], or informing the public about the relevant aspects of
organ donation [11,12]. To optimize the process of donor
procurement, Spain developed an organizational model
('the Spanish model') with policy measures on national,
regional, and hospital level to address the importance of
organ donation and to effectively convert potential
donors into actual donors [13-15].
In many countries these efforts have intensified over time.
However, the shortage of organ donors remains. Accord-
ing to several studies [1,6,16,17]. the number of organ
donations per million inhabitants (PMI) has increased
only in some countries, whereas in most countries it has
been stable or even decreased. Were these policy measures
in vain? An international comparison of the performance
of countries with regard to donor procurement over the
years may provide some insight into the impact of policy
measures in general.
To assess the impact of donor policies and to compare the
performance of the different countries, a valid and reliable
measure is needed. In many studies the national donation
rates PMI are used. Several studies have demonstrated that
using the number of donors PMI does not produce a valid
comparison [1,18-30]. There are significant differences in
the number of potential donors between countries, e.g. in
the numbers of people dying from a CVA or (traffic) acci-
dent. Therefore, a measure which expresses the conversion
of potential donors into effectuated donors PMI produces
a more valid comparison than only the number of effectu-
ated donors as a whole.
The aim of this study is to assess the impact of the donor
policies in 10 Western European countries on donor pro-
curement from 1995 until 2005. This study is part of the
national evaluation of the Dutch Organ Donation Act
[31].
Method
Population
To assess the impact of the donor policies we studied the
conversion of potential donors into effectuated donors in
10 Western European countries. The number of con-
founding factors between countries was restricted by ana-
lysing only countries which share a more or less similar
historical background and have more or less the same sta-
tus of health systems.
The number of potential donors per country
An exact measure for establishing a country's number of
potential donors could be found by analysing all hospital
medical records of deceased persons and identifying all
potential donors [32-34]. Such data are not available for
all countries. In most countries approximately 80% of
donors die of a Cerebral Vascular Accident (CVA) or a traf-
fic accident. A high correlation (Spearman's ρ = 0.81 (P <
0.01)) has been found between these mortality rates and
donation rates [35]. In a study on differences between
Dutch hospitals, Friele et al. also found this high correla-
tion [34]. We therefore considered the national mortality
rates for these causes of death to be a good proxy for the
number of potential donors per country.
Another issue in establishing a country's number of
potential donors is the selection of age groups. The
number of people dying from a CVA increases with age,
especially after the age of 65. Several countries implement
senior donor programs [36,37]. However, except for Spain
[23], the number of effectuated donations from donors
older than 65 years is relatively small. The increase in
mortality rates of CVA among people older than 65 does
not lead to a matching increase in number of donors. The
number of people dying from a CVA who are older than
65 years therefore seems to be of little relevance for a
national proxy of the number of potential donors. In
addition, a strong correlation is found between the mor-
tality rates for CVA and traffic (accidents) among people
younger than 65 and donation rates [35]. We thereforeBMC Health Services Research 2008, 8:235 http://www.biomedcentral.com/1472-6963/8/235
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chose to restrict the proxy for the number of potential
donors to the age groups below 65 years.
The data for CVA and (traffic) accident mortality rates
were derived from the WHO's Health for All Database
(HFA-DB) [38]. The age-standardized mortality rates in
this international and uniform database are based on the
International Statistical Classification of Diseases and
Related Health Problems – 10th Revision (ICD-10).
For some countries the mortality rates for certain years
were missing in the WHO's HFA-DB. Because the mortal-
ity rates in all countries show a steady decrease we decided
it was safe to estimate the missing mortality rates. The
trend lines, which are based on estimated mortality rates,
are shown in the graphs by a dotted line.
The national organ donation rates
Different countries use different definitions for their
national organ donation rates. To counteract these varia-
tions in national definitions we collected new data on the
national number of donors based on one uniform defini-
tion. We asked the national transplant centres to send us
their 'numbers of post mortal organ donors of whom at
least one solid organ had been successfully transplanted
per year'. This definition was preferred because it accounts
for differences between countries in the quality of pro-
cured organs and it has a better coverage of the data in the
period 1995 to 2005. Because France and Sweden could
not provide their data according to this definition for the
entire period (1995–2005), they were asked for their
'numbers of post mortal organ donors of whom at least
one solid organ had been recovered for the purpose of
organ transplantation [39]'.
From the countries that could provide the rates according
to both ways of measuring organ donation rates we
learned that the difference between both rates is no more
than 5% overall. As we use the same definition within
countries, the use of different definitions between coun-
tries does not affect the national trends for organ dona-
tion. Therefore, we found it acceptable to use the rates for
France and Sweden, although they were obtained by using
a deviating definition.
The rates per million inhabitants were calculated using
the population size of the mid-year population given by
the WHO HFA-DB [38].
Analysis
In this study we assess the conversion of potential donors
into actual donors by the donor efficiency rate by proxy.
The donor efficiency rate by proxy is calculated by using
the following definition: (national donation rates PMI/
national mortality rates relevant for organ donation PMI)
* 100. To determine significantly increasing or decreasing
trends, the slopes of the donor efficiency trends of three
time frames (1995–2005, 1995–1999, and 2000–2005)
were calculated using a standard regression analysis.
Consent systems
As several authors report a positive impact of consent sys-
tems on donor procurement [5-7]., we assessed the
impact of consent systems on the donor efficiency rate.
The information on the national consent systems is based
on a legal analysis by Gevers et al. [4]. Table 1 shows infor-
mation about the national consent systems and the
changes which occurred in some countries during the
period under review.
Results: The organ donation rates and the 
national donor efficiency rates by proxy
Figure 1 shows that there are differences between coun-
tries in the mortality rates relevant for donation. These
rates have decreased during the last decade and have
moved slightly towards each other.
Figure 2 shows the organ donation rates PMI in the 10
European countries.
There are large differences between the national organ
donation rates PMI. As often mentioned in other studies,
Spain has by far the highest rate per million inhabitants,
followed by Austria and Belgium. These countries have
twice as many organ donors PMI as for example Germany,
the Netherlands, Sweden, Switzerland and the United
Kingdom.
The impact of donor policies, taking into account differ-
ences in relevant mortality between countries, is demon-
strated by the donor efficiency rates by proxy in figure 3.
This figure shows that some countries have obvious trends
in their donor efficiency rates. For Spain, Italy, France,
Austria, and Germany the donor efficiency rates steadily
increased from 1995 to 2005, whereas Switzerland, the
Netherlands, Belgium, Sweden, and the United Kingdom
have more fluctuating donor efficiency rates. Since the
donor efficiency rates increased in some countries more
than in others, the variance of donor efficiency rates
between countries was larger in 2005 than in 1995.
Table 2 shows the slopes of the donor efficiency trends for
three time frames (1995–1999, 2000–2005 & 1995–
2005).
During the 1995–2005 period, most countries (Spain,
Italy, France, Austria, Germany, Belgium and Switzerland)
showed a significantly rising trend. In the same period the
Netherlands, Sweden and the United Kingdom had no
significant increase in their donor efficiency rates. WeBMC Health Services Research 2008, 8:235 http://www.biomedcentral.com/1472-6963/8/235
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even see that during 1995–1999 the Netherlands as well
as the United Kingdom had a significant decrease in their
donor efficiency rates. The decreasing trend in the Nether-
lands recovered after 2000, showing a significantly rising
trend instead. Likewise, the Swedish donor efficiency sig-
nificantly increased in this period. In addition to figure 3,
table 2 reveals that, on balance, the mean donor efficiency
trend significantly increased during all three time frames.
On average, we did not find obvious differences between
countries with a presumed consent system and countries
with an explicit consent system (figure 3), nor did we find
systematic differences between the slopes of the donor
efficiency rates by proxy of presumed and explicit consent
countries (table 2).
Discussion
The positive impact of donor policies on donor 
procurement
We found a decrease in relevant mortality rates (figure 1),
which is likely to be due to the success of policies on CVA
treatment and traffic safety. The strong correlation
between the mortality rates for CVA and (traffic) accidents
and donation rates [35,40]. means that policy measures
on traffic safety and CVA treatment also have an impact
on donor procurement [41]. For the procurement of
donors the decrease in relevant mortality rates implies
that it has become more difficult to find potential donors
and that more effective strategies are necessary to prevent
a decrease in organ donation rates.
After adjusting the organ donation rates for the changes in
relevant mortality rates, most of the ten countries under
review now demonstrate an increased efficiency in their
donor procurement, implying a positive impact of donor
policies in these countries. Not all countries show a steady
increase in donor efficiency. The variance in donor effi-
ciency rates by proxy increased from 1995 to 2005 (see
figure 3). Apparently, the policies of some countries had
more impact on donor procurement than others. The low
impact of the donor policy in the United Kingdom has
recently been addressed in an editorial by Smith & Mur-
phy [42]. In this publication they report that the British
Organ Donation Taskforce has recommended the imple-
mentation of a new framework for organ donation in the
United Kingdom.
Presumed consent versus informed consent
In our study we found no evidence that presumed consent
systems perform better than explicit consent systems; we
did not find obvious differences between consent systems
(figure 3), nor did we find that donor efficiency rates by
proxy of presumed consent countries increased in a more
accelerated way than those of explicit consent countries
(table 2).
From 1995 until 2005 some countries introduced a new
formal consent system or changed their existing one (see
table 1). These events often go together with mass media
campaigns and changes in the organization of donor pro-
curement. The causality between these events and their
impact on donor procurement is difficult to prove. How-
Table 1: Consent systems in 10 European countries (1995–2005)
Consent systems (according to national legislation effective in 2005)
Presumed consent Spain, Austria, Italy, France, Belgium, Sweden, the United Kingdom1
Explicit consent Germany, the Netherlands, Switzerland
Countries in which the legislative systems changed between 1995 en 2005
Sweden On July 1 1996, Sweden changed from an explicit consent system to a presumed consent system. This change was accompanied 
by an information campaign to the Swedish public. All 4.2 million homes were informed about the system change and were 
neutrally motivated to take a stance in one or more of three ways: by telling next of kin, by signing a donor card, or by notifying 
the National Donor Register, established in 1996 [12].
Germany On December 1 1997, the German Transplantation Act, in which an explicit consent system was laid down, came into force [4]. 
The passing of this Act was accompanied by a long and critical public debate, and several reports on organ donation in all media 
[50].
The Netherlands In January 1998 the Netherlands laid down its explicit consent system in the Dutch Organ Donation Act. Along with the Organ 
Donation Act, a national donor registry (containing consents, refusals, or wishes that next of kin or specific person may decide) 
was implemented [4] and the Dutch Transplant Foundation was established. To accompany the introduction of the Organ 
Donation Act, the Dutch government supported neutral and soft-sell public campaigns [11]. Since 2000 the Dutch government 
has focused more on public recruitment campaigns and on supporting the process of organ donation in hospitals [34,51].
Italy Italy enacted its new transplantation law in 1999, introducing a presumed consent system. The introduction of this new 
legislation was accompanied by the founding of a national transplantation centre in 2000 and improved organization of the 
donation process [52].
1 According to the British Human Tissue Act of 1961 and the Human Organ Transplants Act of 1989 it is necessary to have consent of the donor to 
use his organs (explicit consent). However, when his will is not known it is (according to these Acts) sufficient to determine that the potential 
donor did not register an objection against organ donation. Consequently, the UK had a presumed consent system during the period under review 
[4,53]. By implementing the Human Tissue Act 2004 the UK introduced a formal explicit consent system in September 2006.BMC Health Services Research 2008, 8:235 http://www.biomedcentral.com/1472-6963/8/235
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ever, insight into these events may shed some light on our
findings.
We see that with regard to the system changes in Germany
and Italy there are no differences between the trends
before and after the introduction of the (new) consent sys-
tem. In both countries the donor efficiency trend was
already increasing before the implementation of the new
consent system and continued to increase in the same way
after the introduction (see figure 3).
For Sweden and the Netherlands we do see differences
between the donor efficiency trends before and after the
introduction of their new consent system. The change to
the Swedish system in 1996 led to a temporary increase in
donor efficiency rate by proxy. In 1998 the Swedish donor
efficiency reached the same level as before the introduc-
tion of their presumed consent system. Prior to the imple-
mentation of the Dutch explicit consent system in 1998
the donor efficiency trend was already decreasing, and
one year after the introduction it reached its all-time low.
Since 2001, the Dutch donor efficiency by proxy has
increased. For the Netherlands we know that this proba-
bly has to do with the introduction of a range of new pol-
icy measures [31].
National mortality rates relevant for organ donation per million inhabitants in 10 European countries (1995–2005) Figure 1
National mortality rates relevant for organ donation per million inhabitants in 10 European countries (1995–
2005).
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On the whole, none of the legal changes led to a signifi-
cant change in the trend of a country's donor efficiency
rate by proxy. It seems more likely that the changes in the
donor efficiency trends in Sweden and the Netherlands
were due to the impact of public awareness regarding
organ donation.
Our findings to the effect that having a presumed consent
system does not guarantee higher donation rates and that
changing the consent system does not have a significant
impact on the trends of the donor efficiency rates by proxy
are in concordance with the findings of other studies. In a
legal analysis of consent systems Gevers et al. point out
that in reality the different systems are much more similar
than suggested by the explicit/presumed distinction [4].
They furthermore conclude that in particular the predom-
inant role of relatives, in case no decision of the deceased
has been recorded (as is most frequent in both presumed-
as well as explicit consent countries), reduces the potential
of the presumed consent system. Several studies report the
same finding that also in presumed consent practice the
next of kin are consulted [14,43-46].
Organ donation rates per million inhabitants in 10 European countries (1995–2005) Figure 2
Organ donation rates per million inhabitants in 10 European countries (1995–2005).
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Our findings do not correspond with the findings of stud-
ies using national donation rates PMI to assess the impact
of consent systems [5,6,47]. Abadie et al. conclude that,
after controlling for other determinants for organ dona-
tion, presumed consent has a positive and sizeable effect
on organ donation rates [18]. However, to control for dif-
ferences in potential donors between countries they use
mortality rates for all ages. By using CVA mortality rates of
high age categories, it remains to be seen whether their
method does not overestimate the contribution of CVA
mortality rates to the donor potential.
Limitations
A limitation of this study is that we cannot attribute the
differences in donor efficiency rates by proxy between
countries to specific policy measures. Nonetheless,
according to our results, policies in general do have a pos-
itive impact on donor procurement. It is difficult to deter-
mine which specific policy elements are responsible for
this success. There is no structured overview of specific
donor policy measures per country, or of status of imple-
mentation regarding these measures per year. An excep-
The donor efficiency rates by proxy in 10 European countries (1995–2005) Figure 3
The donor efficiency rates by proxy in 10 European countries (1995–2005).
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tion to this general picture is the Spanish model, the effect
of which has been described many times [13,14].
Another limitation of this study is that the numbers of
potential donors are based on national mortality rates.
Although the WHO puts a lot of effort into optimizing the
reliability of the data, differences between countries in
how they measure the mortality rates may occur. As a reac-
tion to an editorial by Roels et al. [29], Matesanz et al. [48]
conclude in their letter to the Editor that because of these
possible differences, the number of donors PMI is the
most realistic and simple way to make comparisons.
However, neglecting huge differences in mortality rates
between countries does not seem to be an option which
leads to a valid international comparison. Neglecting dif-
ferences in the number of, for example, traffic accidents
will blur a valid comparison between countries regarding
the impact of their donor policy. Besides, for the compar-
ison between years within one country as well, we should
take account of differences in the number of potential
donors each year.
Conclusion
This international comparative study shows that imple-
menting policies for organ donation and putting effort
into the procurement of donors does seem to have a pos-
itive impact on donor procurement in most countries. The
success of donor policies is, however, blurred by the suc-
cess of policies on traffic safety and CVA treatment and is
therefore not revealed by the actual donation rates PMI.
Our results also demonstrate that in some countries
donor policy had greater impact than in others. A gap is
emerging between successful and less successful countries
in this respect. Because there is insufficient information
about which specific policy measures are implemented
per country per year, it is not possible to determine which
measures cause a significant increase in the donor effi-
ciency rates by proxy.
The differences between countries and between years can-
not be explained by differences in consent system
between countries. Factors other than the consent system
seem to be responsible for the differences between coun-
tries regarding the impact of their donor policy. These are
for instance differences between countries regarding the
measures they undertake to optimize the process of donor
procurement (in hospitals), to increase the donor pool
(by using older donors or non heart beating donors) or to
inform the public about the relevant aspects of organ
donation.
Whereas the shortage of donor organs persists, it is impor-
tant to find pointers for the improvement of donor pro-
curement. Because little is known about which specific
policy measures are successful for each country, an organ-
ization like the European Commission, for instance,
should support initiatives that achieve international com-
parable data on national policy measures among EU-
members. In 2007 the European Commission organized
two meetings to discuss organ donation and transplanta-
tion at EU level [49]. In addition, this study points out the
necessity of adjusting such data for fundamental differ-
ences between countries (e.g. relevant mortality rates)
which influence the organ donation rates. This can be
encouraged by using a simple, yet effective method such
as discussed in this study. Applying such a method will
make it possible for policymakers to make evidence based
decisions when implementing organ donation policy
measures.
Nonetheless, policymakers should be aware of the fact
that post mortal organ donation alone will not solve the
long waiting times for patients in need of an organ. There-
fore, other methods of donor procurement, such as
encouraging living donation and the development of an
artificial kidney, should be considered.
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